INVA logo

INVA
Innoviva Inc

1,556
Mkt Cap
$1.7B
Volume
451,860.00
52W High
$25.15
52W Low
$16.52
PE Ratio
7.53
INVA Fundamentals
Price
$23.02
Prev Close
$22.99
Open
$22.90
50D MA
$22.17
Beta
0.28
Avg. Volume
796,654.45
EPS (Annual)
$3.30
P/B
1.46
Rev/Employee
$2.67M
$1,396.70
Loading...
Loading...
News
all
press releases
Oliver Luxxe Assets LLC Makes New $1.69 Million Investment in Innoviva, Inc. $INVA
Oliver Luxxe Assets LLC acquired a new stake in Innoviva, Inc. (NASDAQ:INVA - Free Report) during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor acquired 84,671 shares of the biotechnology company's...
MarketBeat·16d ago
News Placeholder
More News
News Placeholder
Quantbot Technologies LP Lowers Stake in Innoviva, Inc. $INVA
Quantbot Technologies LP cut its stake in Innoviva, Inc. (NASDAQ:INVA - Free Report) by 67.4% during the third quarter, according to the company in its most recent Form 13F filing with the Securities...
MarketBeat·30d ago
News Placeholder
American Century Companies Inc. Buys 284,253 Shares of Innoviva, Inc. $INVA
American Century Companies Inc. grew its position in Innoviva, Inc. (NASDAQ:INVA - Free Report) by 13.8% in the third quarter, according to the company in its most recent Form 13F filing with the...
MarketBeat·1mo ago
News Placeholder
Analysts Offer Predictions for Innoviva FY2027 Earnings
Innoviva, Inc. (NASDAQ:INVA - Free Report) - Research analysts at HC Wainwright issued their FY2027 earnings per share estimates for shares of Innoviva in a report issued on Monday, March 2nd. HC...
MarketBeat·1mo ago
News Placeholder
Innoviva, Inc. (NASDAQ:INVA) Receives Average Recommendation of "Moderate Buy" from Brokerages
Innoviva, Inc. (NASDAQ:INVA - Get Free Report) has been given an average recommendation of "Moderate Buy" by the eight ratings firms that are presently covering the company, MarketBeat Ratings...
MarketBeat·1mo ago
News Placeholder
Innoviva's (INVA) "Buy" Rating Reiterated at BTIG Research
BTIG Research restated a "buy" rating and issued a $35.00 price target on shares of Innoviva in a research report on Thursday...
MarketBeat·1mo ago
News Placeholder
Innoviva (NASDAQ:INVA) Posts Quarterly Earnings Results, Beats Estimates By $1.60 EPS
Innoviva (NASDAQ:INVA - Get Free Report) issued its quarterly earnings results on Wednesday. The biotechnology company reported $1.94 earnings per share for the quarter, topping analysts' consensus...
MarketBeat·1mo ago
News Placeholder
Innoviva Reports Fourth Quarter and Full Year 2025 Financial Results; Highlights Recent Company Progress
Innoviva, Inc. (NASDAQ: INVA) (Innoviva or the Company), a diversified biopharmaceutical company with a core royalties portfolio, a leading critical care and infectious disease platform known as...
Business Wire·1mo ago
News Placeholder
Innoviva (NASDAQ:INVA) Reaches New 52-Week High - Here's What Happened
Innoviva (NASDAQ:INVA) Hits New 1-Year High - Time to Buy...
MarketBeat·1mo ago
News Placeholder
Public Sector Pension Investment Board Increases Holdings in Innoviva, Inc. $INVA
Public Sector Pension Investment Board raised its holdings in shares of Innoviva, Inc. (NASDAQ:INVA - Free Report) by 24.0% in the third quarter, according to its most recent 13F filing with the...
MarketBeat·1mo ago
<
1
2
...
>

Latest INVA News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.